The Australian and New Zealand College of Anaesthetists (ANZCA), the Gastroenterological Society of Australia, the Australian Diabetes Society, and the National Association of Clinical Obesity Services and Australian and New Zealand Metabolic and the Obesity Surgery Society have developed revised recommendations for patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation
You may notice mild appetite reduction and slight nausea, particularly after meals
The Rising Wave of Ozempic Lawsuits: What West Virginians Need to Know The drug Ozempic, which has been widely used for managing diabetes and weight loss, has transitioned from a medical solution to a source of legal scrutiny
It's hard to ignore all the buzz about GLP-1 medications, and now there's a growing class of GLP-1 supplements popping up everywhere
When there is nothing in the stomach to slow down, and GLP-1 signals are telling the brain "you are full," some people experience a wave of nausea that a small amount of food can help buffer
In contrast, long-acting agonists (such as albiglutide or dulaglutide, or extended-release exenetide) have a stronger effect to reduce fasting glucose levels mediated by their effect on insulin and glucagon release